Glenmark Pharmaceuticals Ltd
BSE : 532296
NSE : GLENMARK
Sector :Health care
ISIN Code : INE935A01035
NSE
1550.60
8.95 (0.58%)
Open
1553.90
High
1566.70
Low
1534.80
BSE
1549.95
7.60 (0.49%)
Open
1552.25
High
1565.95
Low
1534.80
Announcement under Regulation 30 (LODR)-Press Release / Media Release
04:01 PM,23rd Dec 2024
Ichnos Glenmark Innovation (IGI) presents first clinical data from phase 1 study of Trisoecific TREAT Antibody ISB 2001 showing high overall response rate (ORR) with durable responses and favourable safety profile in patients with heavily pretreated Multiple Myeloma
